DK538485A - Rekombinante dna-molekyler - Google Patents

Rekombinante dna-molekyler Download PDF

Info

Publication number
DK538485A
DK538485A DK538485A DK538485A DK538485A DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A
Authority
DK
Denmark
Prior art keywords
recombinant dna
dna molecules
molecules
recombinant
dna
Prior art date
Application number
DK538485A
Other languages
English (en)
Other versions
DK538485D0 (da
Inventor
A R Dunn
N M Gough
D Metcalf
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3770545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK538485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp filed Critical Research Corp
Publication of DK538485D0 publication Critical patent/DK538485D0/da
Publication of DK538485A publication Critical patent/DK538485A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK538485A 1984-03-21 1985-11-21 Rekombinante dna-molekyler DK538485A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG417384 1984-03-21
PCT/US1985/000465 WO1985004188A1 (en) 1984-03-21 1985-03-19 Recombinant dna molecules

Publications (2)

Publication Number Publication Date
DK538485D0 DK538485D0 (da) 1985-11-21
DK538485A true DK538485A (da) 1985-11-21

Family

ID=3770545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK538485A DK538485A (da) 1984-03-21 1985-11-21 Rekombinante dna-molekyler

Country Status (8)

Country Link
US (1) US5602007A (da)
EP (2) EP0177568B1 (da)
JP (3) JPS61501490A (da)
AU (2) AU594014B2 (da)
DE (1) DE3587864T2 (da)
DK (1) DK538485A (da)
NL (1) NL940022I1 (da)
WO (1) WO1985004188A1 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57069B1 (en) 1980-04-03 1992-04-22 Biogen Inc Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon
NZ228031A (en) * 1984-07-06 1991-12-23 Sandoz Ltd Primate gm-csf and method of extraction
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
PT81513B (pt) * 1984-11-20 1988-03-03 Schering Biotech Corp Clones de dna codificando polipeptideos que apresentam actividade de factor de crescimento celular para granulocitos, madrofagos e eosinofilos humanos
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
ATE67517T1 (de) * 1985-09-30 1991-10-15 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
EP0232707A1 (en) * 1986-01-09 1987-08-19 Ajinomoto Co., Inc. Human hematopoietic cell growth potentiating factor
US5106733A (en) * 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
EP0413721A4 (en) * 1988-04-21 1991-11-13 Medvet Science Pty. Ltd. Human gm-csf variants
ATE161883T1 (de) * 1989-08-11 1998-01-15 Amrad Corp Ltd Rezeptor für granulozyten-macrophagen- koloniestimulierungsfaktor und seine derivate
DE69430369T2 (de) 1993-09-15 2002-10-17 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Rekombinanter alphavirus vektor
US5777193A (en) * 1994-03-04 1998-07-07 Ludwig Institute For Cancer Research Animals with targeted gene disruption
ATE386811T1 (de) 1996-04-05 2008-03-15 Novartis Vaccines & Diagnostic Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
EP2298900A1 (en) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for treating intracellular diseases
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
ES2297889T3 (es) * 1997-07-14 2008-05-01 Bolder Biotechnology, Inc. Derivados de hormona de crecimiento y proteinas relacionadas.
WO1999017798A1 (en) 1997-10-02 1999-04-15 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US6602705B1 (en) 1998-12-31 2003-08-05 Chiron Corporation Expression of HIV polypeptides and production of virus-like particles
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
WO2000047195A1 (en) * 1999-02-12 2000-08-17 Washington University Stimulating neutrophil function to treat inflammatory bowel disease
EP1309373A2 (en) * 2000-08-11 2003-05-14 Favrille, Inc. Method and composition for altering a t cell mediated pathology
US6911204B2 (en) * 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
EP2292772A1 (en) 2001-07-05 2011-03-09 Novartis Vaccines and Diagnostics, Inc. HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
WO2003068924A2 (en) 2002-02-13 2003-08-21 Ludwig Institute For Cancer Research Fusion proteins of humanized g250 specific antibodies and uses thereof
AU2003228751A1 (en) 2002-05-01 2003-11-17 Cell Genesys, Inc. Lentiviral vector particles resistant to complement inactivation
GB0210741D0 (en) * 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0224415D0 (en) * 2002-10-21 2002-11-27 Medical Res Council Compositions
CA2529710A1 (en) 2003-06-20 2005-03-10 Protein Sciences Corporation Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
CA2585672A1 (en) 2004-11-01 2006-05-11 Novartis Vaccines And Diagnostics Inc. Combination approaches for generating immune responses
GB0524103D0 (en) * 2005-11-26 2006-01-04 Medical Res Council Healing
US7741450B2 (en) 2006-02-08 2010-06-22 Morphotek Inc. Antibodies to GM-CSF
US20100196336A1 (en) 2006-05-23 2010-08-05 Dongsu Park Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US8815229B2 (en) 2009-10-12 2014-08-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Granulysin in immunotherapy
WO2012093258A2 (en) 2011-01-05 2012-07-12 Imperial Innovations Limited Treatment and screening
EP2870238A4 (en) 2012-07-05 2016-03-09 Ohio State Innovation Foundation COMPOSITIONS AND METHODS ASSOCIATED WITH VIRAL VACCINES
WO2017040387A2 (en) 2015-08-31 2017-03-09 Technovax, Inc. Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine
CN109153977B (zh) 2016-01-08 2022-11-01 雷普利穆内有限公司 溶瘤病毒株
EP3443107A1 (en) 2016-04-13 2019-02-20 Synthetic Genomics, Inc. Recombinant arterivirus replicon systems and uses thereof
EP3526332B1 (en) 2016-10-17 2024-06-26 Janssen Pharmaceuticals, Inc. Recombinant virus replicon systems and uses thereof
JP2020500536A (ja) 2016-12-05 2020-01-16 シンセティック ジェノミクス インコーポレーテッド 遺伝子発現増強のための組成物および方法
GB201700350D0 (en) 2017-01-09 2017-02-22 Replimune Ltd Altered virus
US11389531B2 (en) 2017-12-19 2022-07-19 Janssen Sciences Ireland Unlimited Company Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
EA202091513A1 (ru) 2017-12-19 2020-09-09 Янссен Сайенсиз Айрлэнд Анлимитед Компани Вакцины против вируса гепатита b (hbv) и их применение
EA202091516A1 (ru) 2017-12-19 2020-11-03 Янссен Сайенсиз Айрлэнд Анлимитед Компани Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
KR20200111729A (ko) 2018-01-19 2020-09-29 얀센 파마슈티칼즈, 인코포레이티드 재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (da) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4658018A (en) * 1984-03-13 1987-04-14 Immunex Corporation Process for producing homogeneous colony stimulating factor
NZ228031A (en) * 1984-07-06 1991-12-23 Sandoz Ltd Primate gm-csf and method of extraction
PT81513B (pt) * 1984-11-20 1988-03-03 Schering Biotech Corp Clones de dna codificando polipeptideos que apresentam actividade de factor de crescimento celular para granulocitos, madrofagos e eosinofilos humanos
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use

Also Published As

Publication number Publication date
JPH10165190A (ja) 1998-06-23
AU629938B2 (en) 1992-10-15
EP0574029A1 (en) 1993-12-15
AU5589390A (en) 1990-09-13
AU4008485A (en) 1985-09-26
DE3587864T2 (de) 1994-09-29
EP0177568B1 (en) 1994-06-22
NL940022I1 (nl) 1995-01-02
DE3587864D1 (de) 1994-07-28
DK538485D0 (da) 1985-11-21
US5602007A (en) 1997-02-11
EP0177568A4 (en) 1987-10-08
WO1985004188A1 (en) 1985-09-26
AU594014B2 (en) 1990-03-01
JPH09271A (ja) 1997-01-07
EP0177568A1 (en) 1986-04-16
JPS61501490A (ja) 1986-07-24

Similar Documents

Publication Publication Date Title
DK538485A (da) Rekombinante dna-molekyler
DK467385A (da) Dna-fragmenter
DK552285A (da) Proteinkonjugat
DK112586D0 (da) Virus-dna
DK180486D0 (da) Varmeapparat
DK224886D0 (da) Proteinbestemmelse
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
GB8404378D0 (en) Dna sequence recombinant dna molecules
BR8600164A (pt) Coluna de fracionamento
DK600586A (da) Protein
NO170503C (no) Broennhull-proevetaker
DK395385D0 (da) Varmeapparat
FI852866A0 (fi) Rekombinantfaktor viii-r.
DE3582362D1 (de) Elektrophoretisches element.
DK319888A (da) Dna-fragmenter
GB8406569D0 (en) Recombinant dna molecules
GB8319265D0 (en) Recombinant dna molecules
NO850732L (no) Rekombinante dna-molekyler
DK51585A (da) Proteinkoncentrater
DK161609C (da) Elektroforeseanordning
GB8619300D0 (en) Recombinant dna molecules
ES278395Y (es) Pipeta mejorada
DK286D0 (da) Elektroforeseapparat
GB8405655D0 (en) Molecules by electrophoresis
SE8505275D0 (sv) Armering

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment